Replies to post #302990 on Innovation Pharmaceuticals Inc (IPIX)

[Patientspeople]

Buy Out like Pharmacyclics not going to be another Regeneron.

IMO There's no way Leo and his tiny inexperienced crew has the horsepower to follow the Regeneron model. Try the Pharmacyclics model of having 3-4 BP suiters outbidding each other for the rights to Brilacidin and Kevetrin once human trials prove to be a home run with COVID-19... It will be HUGE!!!!

Extreme example but it happed: 2015, AbbVie bought Pharmacyclics (half the rights of Imbruvica for $261.00 a share) after heavy bidding by J&J, Pfizer and winner AbbVie .... J&J already owned the rights to the other half of Imbruvica/Imatinib after paying Pharmacyclics almost 1 Billion dollars and funding double digit trials that were under way. I know, I was there at start up through the Buyout.

That's how you do it LEO!!!